Evidence mapPaperPMID 35246121Full record

ArticleCardiovascular diabetology2022

Lower miR-21/ROS/HNE levels associate with lower glycemia after habit-intervention: DIAPASON study 1-year later.

Lucia La Sala, Elena Tagliabue, Simona Mrakic-Sposta, Anna Chiara Uccellatore, Pamela Senesi, Ileana Terruzzi, Emilio Trabucchi, Luigi Rossi-Bernardi, Livio Luzi

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Lucia La SalaIRCCS, MultiMedica, PST-Via Fantoli 16/15, 20138, Milan, MI, Italy. lucia.lasala@multimedica.it.
Elena TagliabueIRCCS, MultiMedica, PST-Via Fantoli 16/15, 20138, Milan, MI, Italy.
Simona Mrakic-SpostaInstitute of Clinical Physiology, National Research Council (CNR), 20162, Milan, Italy.
Anna Chiara UccellatoreICCS Istituto Clinico Città Studi, Milan, Italy.
Pamela SenesiIRCCS, MultiMedica, PST-Via Fantoli 16/15, 20138, Milan, MI, Italy.
Ileana TerruzziIRCCS, MultiMedica, PST-Via Fantoli 16/15, 20138, Milan, MI, Italy.
Emilio TrabucchiIRCCS, MultiMedica, PST-Via Fantoli 16/15, 20138, Milan, MI, Italy.
Luigi Rossi-Bernardi, Milan, Italy.
Livio LuziIRCCS, MultiMedica, PST-Via Fantoli 16/15, 20138, Milan, MI, Italy.
MultiMedica · ITUniversity of Milan · ITIstituto di Sessuologia Clinica · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of prediabetes is increasing in the global population and its metabolic derangements may expose to a higher risk to develop type 2 diabetes (T2D) and its cardiovascular burden. Lifestyle modifications might have considerable benefits on ameliorating metabolic status. Alternative biomarkers, such as circulating miR-21, has been recently discovered associated with dysglycemia. Here we evaluated, in a longitudinal cohort of dysglycemic population the relation between the circulating miR-21/ROS/HNE levels and the habit-intervention (HI) after 1 year of follow-up.

methods1506 subjects from DIAPASON study were screened based on the Findrisc score. Of them, 531 subjects with Findrisc ≥ 9 were selected for dysglycemia (ADA criteria) and tested for circulating miR-21, ROS and HNE levels, as damaging-axis. 207 subjects with dysglycemia were re-evaluated after 1-year of habit intervention (HI). Repeated measures tests were used to evaluate changes from baseline to 1-year of follow-up. The associations between glycemic parameters and miR-21/ROS/HNE were implemented by linear regression and logistic regression models.

resultsAfter HI, we observed a significant reduction of miR-21/ROS/HNE axis in dysglycemic subjects, concomitantly with ameliorating of metabolic parameters, including insulin resistance, BMI, microalbuminuria, reactive hyperemia index and skin fluorescence. Significant positive interaction was observed between miR-21 axis with glycaemic parameters after HI. Lower miR-21 levels after HI, strongly associated with a reduction of glycemic damaging-axis, in particular, within-subjects with values of 2hPG < 200 mg/dL.

conclusionsOur findings demonstrated that HI influenced the epigenetic changes related to miR-21 axis, and sustain the concept of reversibility from dysglycemia. These data support the usefulness of novel biological approaches for monitoring glycemia as well as provide a screening tool for preventive programmes.

Indexed as

Diabetes Mellitus, Type 2MicroRNAsPrediabetic StateBlood GlucoseHabitsHumansReactive Oxygen SpeciesBlood GlucoseMicroRNAsMIRN21 microRNA, humanReactive Oxygen SpeciesDysglycemiaGlucose monitoringHabit-interventionHydroxynonenalMediterranean dietmicroRNA-21miR-21PrediabetesROS

Identifiers

PMID35246121
PMCPMC8895587
OpenAlexW4214879537

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.